UBS lowers Peloton stock price target on churn concerns

UBS cut Peloton's price target to $10 from $11 and reduced its FY2027 EBITDA estimate to $491 million from $526 million, citing elevated churn, although it retained a Buy rating. Peloton's fiscal Q4 adjusted EPS of $0.13 and $608 million of revenue modestly exceeded consensus estimates of $0.12 and $597.4 million, respectively. The earnings beat and more than $1.2 billion cash balance are offset by expectations for an 8%-8.5% FY2027 subscriber decline and broader analyst concern over weakening customer acquisition.

Analysis

The core debate is no longer liquidity but whether Peloton can stabilize its recurring-revenue base before hardware demand normalizes downward. A roughly 8% subscriber contraction would pressure high-margin subscription mix and make a ~$500 million EBITDA outcome increasingly dependent on cost discipline rather than durable top-line recovery; that distinction limits multiple expansion even if reported EBITDA meets guidance. The relevant valuation risk is therefore a guidance-quality reset: investors may be underwriting a turnaround multiple on earnings that are vulnerable to another churn-driven revision.

Near term, the shares can trade higher on evidence that lower-priced product launches improve gross additions without sacrificing hardware gross margin. Over the next 1-3 months, monthly churn, paid-subscriber retention commentary, and any change in marketing spend per acquisition matter more than an incremental equipment-revenue beat. Over 6-18 months, a successful new category could expand the addressable market, but it also raises execution and inventory risk; a weak launch would reinforce the view that Peloton is a shrinking installed-base business.

Consensus may be too focused on the cash cushion and too dismissive of the operating leverage embedded in retention. If churn remains elevated, fixed content, technology, and fulfillment costs can cause EBITDA to miss disproportionately despite modest revenue declines. Conversely, modest retention improvement could create meaningful equity upside because the enterprise value is low relative to guided EBITDA, but that requires independently observable stabilization rather than management-adjusted earnings delivery.

Key Decisions for Investors

• Maintain PTON as a watchlist long rather than initiate before the next subscriber/churn disclosure. Upgrade to a tactical 3-6 month long only if paid-subscriber decline moderates materially and management holds FY27 EBITDA guidance without incremental restructuring; target a rerating toward 6-7x EBITDA, with risk controlled by exiting on a renewed guidance cut.
• For existing PTON exposure, reduce or hedge into product-launch rallies if gross additions rise while churn remains near current elevated assumptions. That combination can temporarily support revenue but worsens lifetime-value economics and raises the probability of margin disappointment over the following 2-3 quarters.
• Consider a small PLNT relative long versus PTON only if consumer data show sustained migration from connected fitness to low-cost gyms; PLNT is a cleaner beneficiary of value-oriented fitness demand, though the relationship is indirect and should not be treated as a high-conviction pair.
• Set an alert for evidence that acquisition costs are rising faster than gross additions or that subscription revenue/margin decelerates despite equipment strength. Either would falsify the cash-conversion case and supports a short bias on PTON after any earnings-driven squeeze.